ImmunityBio Aktie

2,12 EUR +0,05 EUR +2,42 %

24.10.2025

BMN

2,48 USD +0,02 USD +0,61 %

nachbörslich01:14:47

BTT

ImmunityBio jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.1,94 Mrd. EUR

Div. Rendite0,00%

WKNA2QQ2E

ISINUS45256X1037

SymbolIBRX

ImmunityBio Aktien News

Sortieren:Datum Meistgelesen

26.08.25BenzingaWhat's Going On With ImmunityBio Shares Tuesday?

07.08.25finanzen.netImmunityBio stellte Ergebnisse des abgelaufenen Quartals vor

05.08.25ZacksImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates

WerbungImmunityBio-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

15.05.25ZacksImmunityBio (IBRX) Moves to Buy: Rationale Behind the Upgrade

14.05.25finanzen.netImmunityBio: So schnitt der Konzern im vergangenen Quartal ab

12.05.25ZacksImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates

05.05.25BenzingaImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug

01.05.25ZacksImmunityBio (IBRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

06.03.25BenzingaImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug

05.03.25finanzen.netImmunityBio öffnete die Bücher zum abgelaufenen Quartal

03.03.25ZacksImmunityBio (IBRX) Reports Q4 Loss, Misses Revenue Estimates

20.01.25BenzingaIonQ, H&E Equipment Services And ImmunityBio Are Among Top Mid Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

16.01.25BenzingaImmunityBio Stock Trading Higher On Updates From Bladder Cancer Trials: Details

11.12.24BenzingaWhat's Going On With ImmunityBio Shares Wednesday?

21.11.24PR NewswireImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment

19.11.24ZacksWall Street Analysts Think ImmunityBio (IBRX) Could Surge 184.43%: Read This Before Placing a Bet

19.11.24PR NewswireImmunityBio, Inc. Investor Alert (NASDAQ: IBRX): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements

14.11.24finanzen.netImmunityBio: Bilanzvorlage zum letzten Quartal

12.11.24ZacksImmunityBio (IBRX) Reports Q3 Loss, Tops Revenue Estimates

28.10.24ZacksImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?

27.10.24BenzingaTrump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?

11.10.24PR NewswireIMMUNITYBIO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX

14.08.24finanzen.netImmunityBio präsentierte Bilanzzahlen zum jüngsten Jahresviertel

11.05.24finanzen.netImmunityBio informierte über die jüngsten Quartalsergebnisse

28.08.23PR NewswireSHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. (IBRX) Shareholders

18.08.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX

15.08.23PR NewswireIBRX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. Shareholders

14.08.23PR NewswireROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX

14.08.23PR NewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating ImmunityBio, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

10.08.23PR NewswireIBRX LAWSUIT ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

04.08.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX

31.07.23PR NewswireIBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit

28.07.23PR NewswireIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio Shareholders of a Lead Plaintiff Deadline of August 29, 2023

27.07.23PR NewswireIBRX LAWSUIT ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

25.07.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX

21.07.23PR NewswireIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio Shareholders of a Lead Plaintiff Deadline of August 29, 2023

12.07.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX

05.07.23PR NewswireCalling All ImmunityBio, Inc. (IBRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today!

19.05.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX

04.03.22finanzen.netNantKwest: Quartalsergebnisse zum jüngsten Jahresviertel

ImmunityBio News

ImmunityBio News: auf dieser Seite finden Sie alle ImmunityBio News und Nachrichten zur ImmunityBio Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch ImmunityBio News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um ImmunityBio News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.